Gennady Bratslavsky

Co-Founder & Partner

Dr. Gennady Bratslavsky is the Co-Founder & Partner of Avicella Capital. He is an NCI/NIH trained surgeon-scientist and clinical investigator and Professor of Urology, Molecular Biology and Biochemistry. Dr. Bratslavsky has author of over 200 scientific peer reviewed articles and chapters and invited presenter at over 100 international conferences and is the co-inventor of several patents in the field of AI technology, devices, antibody methodology, and small molecules.

Dr. Bratslavsky is an FDA consultant and member of the National Cancer Institute (NCI) Steering Committee. He was the past-President of SUO-CTC: Society of Urologic Oncology Clinical Trial Consortium, the largest in the world of clinical trials in urologic oncology.